Your session is about to expire
← Back to Search
Superior laryngeal nerve block for Superior Laryngeal Nerve Block
Phase 2
Waitlist Available
Led By Courtney Tipton
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, every two weeks (+/- 1 week) post-treatment (estimated 3 months total)
Summary
This trial is testing if injections near a specific throat nerve can reduce coughing in adults with an overactive nerve. Participants will receive either the actual treatment or a non-active treatment. The goal is to see if these injections can help lessen their cough.
Eligible Conditions
- Superior Laryngeal Nerve Block
- Chronic Cough
- Psychogenic Cough
- Cough
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ every two weeks (+/- 1 week) post-treatment (estimated 3 months total), 3 months post completion of therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every two weeks (+/- 1 week) post-treatment (estimated 3 months total), 3 months post completion of therapy
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in cough severity
Secondary study objectives
Coughing
Subjective improvement in cough
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Steroid-Lidocaine MixtureExperimental Treatment2 Interventions
Will receive numbing injection, which is a mixture of steroid and lidocaine
Group II: PlaceboPlacebo Group2 Interventions
Will receive saline injection as a placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Superior laryngeal nerve block
2024
Completed Phase 2
~100
Injection of steroid-lidocaine mixture
2020
Completed Phase 2
~20
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
972 Previous Clinical Trials
7,399,283 Total Patients Enrolled
Courtney TiptonPrincipal Investigator - Medical University of South Carolina
MUSC Children's Hospital, Medical University of South Carolina
Share this study with friends
Copy Link
Messenger